← Leaderboards
Robert I. Haddad
Dana-Farber Cancer Inst
$1,419,734
Attributed
$4,259,203
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$4,259,203 · 1
By mechanism
U01$4,259,203 · 1
Top collaborators
- David A Barbie1 shared
- Ravindra Uppaluri1 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Piotr Sicinski$42,703,610
- David A Barbie$12,794,638
- Frank S Hodi$11,927,265
- Kai W Wucherpfennig$37,935,181
- Xiaofeng Wang$2,865,626
Others in their field
Other Emerging Leaders on “Anti-Pd-1”
- John Freymann · Leidos Biomedical Research, Inc.$5,261,900
- Tina Garyantes · Linnaeus Therapeutics, Llc$5,000,000
- Amaia Lujambio · Icahn School Of Medicine At Mount Sinai$4,251,878
- Alexander Huang · University Of Pennsylvania$3,639,634
- Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill$3,602,417
- Jun Wang · New York University School Of Medicine$3,408,076
Research focus
Anti-Pd-1Anti-Pd1 TherapyAutomobile DrivingBaseBiological MarkersBiological ModelsBiologyCandidate Disease GeneCandidate ValidationCatalytic DomainCategoriesCell LineCell-Mediated CytolysisCellsChromatinChromatin RemodelingCisplatinClinical DevelopmentClinical ManagementClinical TranslationClinical TrialsComplementComplexAnti-Ctla4